Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin and nortriptyline for prevention of chronic post-surgical pain after hip or knee arthroplasty
ACTRN12614000379617Phase 4Not yet recruiting
- Sponsor
- University of Otago
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of gabapentin and nortriptyline in Persistent postsurgical pain (PPSP) (2 arms), sponsored by University of Otago. Primary endpoint: Presence or absence of chronic pain. Planned start Apr 2014; status: not yet recruiting.
02
Drugs
gabapentinnortriptyline
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on ACTRN12614000379617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000379617.